M G T Raraty

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. pmc Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
    Asma Sultana
    Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
    BMC Cancer 9:66. 2009
  2. ncbi request reprint Mechanisms of acinar cell injury in acute pancreatitis
    M G T Raraty
    Division of Surgery and Oncology, University of Liverpool, Liverpool L69 3BX, UK
    Scand J Surg 94:89-96. 2005
  3. ncbi request reprint [Adjuvant and additive therapy for cancer of the pancreas]
    J P Neoptolemos
    Department of Surgery, Liverpool University, Liverpool, United Kingdom
    Chirurg 74:191-201. 2003
  4. ncbi request reprint Adjuvant therapy in pancreatic cancer: historical and current perspectives
    J P Neoptolemos
    Department of Surgery, University of Liverpool, Liverpool, UK
    Ann Oncol 14:675-92. 2003
  5. ncbi request reprint Review article: chemotherapy for pancreatic cancer
    S Shore
    University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK
    Aliment Pharmacol Ther 18:1049-69. 2003
  6. ncbi request reprint Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy
    C M Halloran
    Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
    Br J Surg 95:453-9. 2008
  7. ncbi request reprint Early and late complications after pancreatic necrosectomy
    S Connor
    Department of Surgery, Royal Liverpool University Hospital
    Surgery 137:499-505. 2005
  8. ncbi request reprint Familial pancreatic cancer: a review and latest advances
    C J Grocock
    Division of Surgery and Oncology, The University of Liverpool, United Kingdom
    Adv Med Sci 52:37-49. 2007

Collaborators

Detail Information

Publications8

  1. pmc Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
    Asma Sultana
    Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
    BMC Cancer 9:66. 2009
    ..This study aimed to evaluate the safety and tolerability of KAb201, an anti-carcinoembryonic antigen monoclonal antibody, labelled with I(131) in pancreatic cancer (ISRCTN 16857581)...
  2. ncbi request reprint Mechanisms of acinar cell injury in acute pancreatitis
    M G T Raraty
    Division of Surgery and Oncology, University of Liverpool, Liverpool L69 3BX, UK
    Scand J Surg 94:89-96. 2005
    ..Cytokines and neutrophil activation are also responsible for the systemic inflammatory response typically seen in severe acute pancreatitis...
  3. ncbi request reprint [Adjuvant and additive therapy for cancer of the pancreas]
    J P Neoptolemos
    Department of Surgery, Liverpool University, Liverpool, United Kingdom
    Chirurg 74:191-201. 2003
    ..Participation in the large, phase-3 study therefore plays a key role in the continued development of the management of pancreas cancer...
  4. ncbi request reprint Adjuvant therapy in pancreatic cancer: historical and current perspectives
    J P Neoptolemos
    Department of Surgery, University of Liverpool, Liverpool, UK
    Ann Oncol 14:675-92. 2003
    ....
  5. ncbi request reprint Review article: chemotherapy for pancreatic cancer
    S Shore
    University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK
    Aliment Pharmacol Ther 18:1049-69. 2003
    ..Real advances are anticipated over the next five years but are dependent on large randomised controlled trials for success...
  6. ncbi request reprint Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy
    C M Halloran
    Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
    Br J Surg 95:453-9. 2008
    ..The present prospective study assessed the strategy of using carbohydrate antigen 19.9 (CA19.9) levels to select patients for L-LUS...
  7. ncbi request reprint Early and late complications after pancreatic necrosectomy
    S Connor
    Department of Surgery, Royal Liverpool University Hospital
    Surgery 137:499-505. 2005
    ..Surgery for pancreatic necrosis is associated with a high morbidity and mortality. The aim of this study was to review the incidence of early and late complications after pancreatic necrosectomy in a large contemporary series of patients...
  8. ncbi request reprint Familial pancreatic cancer: a review and latest advances
    C J Grocock
    Division of Surgery and Oncology, The University of Liverpool, United Kingdom
    Adv Med Sci 52:37-49. 2007
    ....